Platelet-to-Lymphocyte Ratio (PLR) as the Prognostic Factor for Recurrence/Residual Disease in HSIL Patients After LEEP

References

• Sung H, Ferlay J, Siegel RL., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Alrajjal A, Pansare V, Choudhury MSR, Khan MYA, Shidham VB. Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System. Cytojournal. 2021;18:16. doi:10.25259/Cytojournal_24_2021
   PubMed Web of Science ®Google Scholar
• Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102–131. doi:10.1097/LGT.0000000000000525
   PubMed Web of Science ®Google Scholar
• Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004;191(1):105–113. doi:10.1016/j.ajog.2004.01.043
   PubMed Web of Science ®Google Scholar
• Castle PE, Schiffman M, Wheeler CM, et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113(1):18–25. doi:10.1097/AOG.0b013e31818f5008
   PubMed Web of Science ®Google Scholar
• Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12(2):186–192. doi:10.1097/00004347-199304000-00018
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• D’Alessandro P, Arduino B, Borgo M, et al. Loop Electrosurgical Excision Procedure versus Cryotherapy in the Treatment of Cervical Intraepithelial Neoplasia: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Gynecol Minim Invasive Ther. 2018;7(4):145–151. doi:10.4103/GMIT.GMIT_56_18
   PubMed Web of Science ®Google Scholar
• Santesso N, Mustafa RA, Wiercioch W, et al. Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2016;132(3):266–271. doi:10.1016/j.ijgo.2015.07.026
   PubMed Web of Science ®Google Scholar
• Sun P, Song Y, Ruan G, et al. Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study. J Gynecol Oncol. 2017;28(5):e50. doi:10.3802/jgo.2017.28.e50
   PubMed Web of Science ®Google Scholar
• Chen L, Dong B, Zhang Q, et al. HR-HPV viral load quality detection provide more accurate prediction for residual lesions after treatment: a prospective cohort study in patients with high-grade squamous lesions or worse. Med Oncol. 2020;37(5):37. doi:10.1007/s12032-020-01363-z
   PubMed Web of Science ®Google Scholar
• Kalogirou D, Antoniou G, Karakitsos P, et al. Predictive factors used to justify hysterectomy after loop conization: increasing age and severity of disease. Eur J Gynaecol Oncol. 1997;18(2):113–116.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Redman CWE, Verdoodt F, et al. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. Lancet Oncol. 2017;18(12):1665–1679. doi:10.1016/S1470-2045(17)30700-3
   PubMed Web of Science ®Google Scholar
• Kao SC, Pavlakis N, Harvie R, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010;16(23):5805–5813. doi:10.1158/1078-0432.CCR-10-2245
   PubMed Web of Science ®Google Scholar
• Diem S, Schmid S, Krapf M, et al. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017;111:176–181. doi:10.1016/j.lungcan.2017.07.024
   PubMed Web of Science ®Google Scholar
• Zhu M, Feng M, He F, et al. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer. Clin Chim Acta. 2018;483:296–302. doi:10.1016/j.cca.2018.05.025
   PubMed Web of Science ®Google Scholar
• Han X, Liu S, Yang G, et al. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: a systemic review, meta-analysis, and meta-regression of observational studies. Gynecol Oncol. 2021;160(1):351–360. doi:10.1016/j.ygyno.2020.10.011
   PubMed Web of Science ®Google Scholar
• Xu M, Wu Q, Cai L, Sun X, Xie X, Sun P. Systemic Inflammatory Score predicts Overall Survival in patients with Cervical Cancer. J Cancer. 2021;12(12):3671–3677. doi:10.7150/jca.56170
   PubMed Web of Science ®Google Scholar
• Tas M, Yavuz A, Ak M, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Discriminating Precancerous Pathologies from Cervical Cancer. J Oncol. 2019;2019:2476082. doi:10.1155/2019/2476082
   PubMed Web of Science ®Google Scholar
• Barnes PW, McFadden SL, Machin SJ, Simson E. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. Lab Hematol. 2005;11(2):83–90. doi:10.1532/LH96.05019
   PubMedGoogle Scholar
• Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114–2119. doi:10.1001/jama.287.16.2114
   PubMed Web of Science ®Google Scholar
• Apgar BS, Zoschnick L, Wright TC. The 2001 Bethesda System terminology. Am Fam Physician. 2003;68(10):1992–1998.
   PubMed Web of Science ®Google Scholar
• Reich O, Regauer S, Marth C, et al. Precancerous Lesions of the Cervix, Vulva and Vagina According to the 2014 WHO Classification of Tumors of the Female Genital Tract. Geburtshilfe Frauenheilkd. 2015;75(10):1018–1020. doi:10.1055/s-0035-1558052
   PubMed Web of Science ®Google Scholar
• Waxman AG, Chelmow D, Darragh TM, et al. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol. 2012;120(6):1465–1471. doi:10.1097/AOG.0b013e31827001d5
   PubMed Web of Science ®Google Scholar
• Kang Y, Sun P, Mao X, et al. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort. J Gynecol Oncol. 2019;30(3):e29. doi:10.3802/jgo.2019.30.e29
   PubMed Web of Science ®Google Scholar
• Hoffman SR, Le T, Lockhart A, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review. Int J Cancer. 2017;141(1):8–23. doi:10.1002/ijc.30623
   PubMed Web of Science ®Google Scholar
• Feliciano EMC, Kroenke CH, Meyerhardt JA, et al. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: results From the C SCANS Study. JAMA Oncol. 2017;3(12):e172319. doi:10.1001/jamaoncol.2017.2319
   PubMed Web of Science ®Google Scholar
• Nishida J, Momoi Y, Miyakuni K, et al. Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis. Nat Cell Biol. 2020;22(4):465–475. doi:10.1038/s41556-020-0491-2
   PubMed Web of Science ®Google Scholar
• Zhang HY, Xie HL, Ruan GT, et al. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer. BMC Cancer. 2022;22(1):1080. doi:10.1186/s12885-022-10145-x
   PubMed Web of Science ®Google Scholar
• Chao B, Ju X, Zhang L, Xu X, Zhao Y. A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients. Front Oncol. 2020;10:766. doi:10.3389/fonc.2020.00766
   PubMed Web of Science ®Google Scholar
• Huang H, Liu Q, Zhu L, et al. Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer. Sci Rep. 2019;9(1):3284. doi:10.1038/s41598-019-39150-0
   PubMed Web of Science ®Google Scholar
• Lei H, Xu S, Mao X, et al. Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer. J Inflamm Res. 2021;14:7131–7142. doi:10.2147/JIR.S345790
   PubMed Web of Science ®Google Scholar
• Chun S, Shin K, Kim KH, et al. The Neutrophil-Lymphocyte Ratio Predicts Recurrence of Cervical Intraepithelial Neoplasia. J Cancer. 2017;8(12):2205–2211. doi:10.7150/jca.19173
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, et al. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–503. doi:10.1016/S1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Hammes LS, Tekmal RR, Naud P, et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression--clinicopathological correlation. Gynecol Oncol. 2007;105(1):157–165. doi:10.1016/j.ygyno.2006.11.023
   PubMed Web of Science ®Google Scholar
• Long T, Long L, Chen Y, et al. Severe cervical inflammation and high-grade squamous intraepithelial lesions: a cross-sectional study. Arch Gynecol Obstet. 2021;303(2):547–556. doi:10.1007/s00404-020-05804-y
   PubMed Web of Science ®Google Scholar
• Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47(17):2633–2641. doi:10.1016/j.ejca.2011.03.028
   PubMed Web of Science ®Google Scholar
• Farzaneh F, Faghih N, Hosseini MS, et al. Evaluation of Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Cervical Intraepithelial Neoplasia Recurrence. Asian Pac J Cancer Prev. 2019;20(8):2365–2372. doi:10.31557/APJCP.2019.20.8.2365
   PubMedGoogle Scholar
• Bilir F, Chkhikvadze M, Yilmaz AY, et al. Prognostic value of systemic inflammation response index in patients with persistent human papilloma virus infection. Ginekol Pol. 2022;93(9):705–709. doi:10.5603/GP.a2021.0200
   PubMed Web of Science ®Google Scholar
• Brewczyński A, Jabłońska B, Mazurek AM, et al. Comparison of Selected Immune and Hematological Parameters and Their Impact on Survival in Patients with HPV-Related and HPV-Unrelated Oropharyngeal Cancer. Cancers. 2021;13(13):3256. doi:10.3390/cancers13133256
   PubMed Web of Science ®Google Scholar
• Rabinowich H, Cohen R, Bruderman I, et al. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res. 1987;47(1):173–177.
   PubMed Web of Science ®Google Scholar
• D’Agostino M, Di Cecco M, Marani C, et al. Positive Linear Relationship between Nucleophosmin Protein Expression and the Viral Load in HPV-Associated Oropharyngeal Squamous Cell Carcinoma: a Possible Tool for Stratification of Patients. Int J Mol Sci. 2023;24(4):3482. doi:10.3390/ijms24043482
   PubMed Web of Science ®Google Scholar
• Somineni HK, Venkateswaran S, Kilaru V, et al. Blood-Derived DNA Methylation Signatures of Crohn’s Disease and Severity of Intestinal Inflammation. Gastroenterology. 2019;156(8):2254–2265.e2253. doi:10.1053/j.gastro.2019.01.270
   PubMed Web of Science ®Google Scholar
• Tomlinson MS, Bommarito PA, Martin EM, et al. Microorganisms in the human placenta are associated with altered CpG methylation of immune and inflammation-related genes. PLoS One. 2017;12(12):e0188664. doi:10.1371/journal.pone.0188664
   PubMed Web of Science ®Google Scholar
• Fu K, Lei M, Wu LS, et al. Triage by PAX1 and ZNF582 Methylation in Women With Cervical Intraepithelial Neoplasia Grade 3: a Multicenter Case-Control Study. Open Forum Infect Dis. 2022;9(5):ofac013. doi:10.1093/ofid/ofac013
   PubMed Web of Science ®Google Scholar
• Li B, Guo R, Lai T, Qiao L, Fu H. The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening. J Obstet Gynaecol Res. 2021;47(8):2720–2728. doi:10.1111/jog.14869
   PubMed Web of Science ®Google Scholar
• Giorgi Rossi P, Carozzi F, Ronco G, et al. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women. J Natl Cancer Inst. 2021;113(3):292–300. doi:10.1093/jnci/djaa105
   PubMedGoogle Scholar
• Kühn JP, Schmid W, Körner S, et al. HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction? Cancers. 2021;13(18):4730. doi:10.3390/cancers13184730
   PubMed Web of Science ®Google Scholar
• He Q, Li L, Ren Q. The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram. Front Oncol. 2021;11:671811. doi:10.3389/fonc.2021.671811
   PubMed Web of Science ®Google Scholar
• Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med. 1998;13(5):335–346. doi:10.1046/j.1525-1497.1998.00101.x
   PubMed Web of Science ®Google Scholar
• Wilson J. Management of bacterial vaginosis. Drug Ther Bull. 1998;36(5):33–35. doi:10.1136/dtb.1998.36533
   PubMedGoogle Scholar
• Santella B, Schettino MT, Franci G, et al. Microbiota and HPV: the role of viral infection on vaginal microbiota. J Med Virol. 2022;94(9):4478–4484. doi:10.1002/jmv.27837
   PubMed Web of Science ®Google Scholar
• Dong B, Huang Y, Cai H, et al. Prevotella as the hub of the cervicovaginal microbiota affects the occurrence of persistent human papillomavirus infection and cervical lesions in women of childbearing age via host NF-κB/C-myc. J Med Virol. 2022;94(11):5519–5534. doi:10.1002/jmv.28001
   PubMed Web of Science ®Google Scholar
• Lin W, Zhang Q, Chen Y, et al. Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis. Sci Rep. 2022;12(1):2812. doi:10.1038/s41598-022-06731-5
   PubMed Web of Science ®Google Scholar
• Pek E, Beyazit F, Korkmaz NS. Predictive value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Vaginitis. Pak J Med Sci. 2021;37(1):250–255. doi:10.12669/pjms.37.1.2774
   PubMed Web of Science ®Google Scholar